BIO Invites Nominations for the 2011 George Washington Carver Award for Innovation in Industrial BiotechnologyFeb 28 2011
The fourth annual George Washington Carver Award will recognize an individual who has demonstrated significant and innovative accomplishments that have employed industrial biotechnology to facilitate the advancement of a biobased economy and industrial sustainability.
|
|
World’s Farmers Favor Biotech Crop VarietiesFeb 22 2011
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2010, says a record 15.4 million farmers in 29 countries are growing biotech crops on 366 million acres.
|
|
BIO Hails U.S. Supreme Court Decision on Vaccine ActFeb 22 2011
BIO issues statement commending today’s ruling by the U.S. Supreme Court in Bruesewitz v. Wyeth.
|
|
BIO Urges U.S. Trade Representative to Preserve IP Protection AbroadFeb 21 2011
The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.
|
|
BIO Applauds Appointment of Rea as Deputy Director of U.S. PTOFeb 17 2011
BIO welcomes the announcement of the appointment of Teresa Stanek Rea as Deputy Director of the U.S. Patent and Trademark Office (PTO).
|
|
BIO’s Brent Erickson Appointed to SynBERC Scientific Advisory BoardFeb 15 2011
Brent Erickson, executive vice president of the Biotechnology Industry Organization’s (BIO) Industrial & Environmental Section, has been named to the Scientific Advisory Board of the Synthetic Biology Engineering Research Center (SynBERC).
|
|
Biotechnology Industry Organization (BIO) To Ring The NASDAQ Stock Market Closing BellFeb 14 2011
The Biotechnology Industry Organization (BIO) will visit the NASDAQ MarketSite in New York City's Times Square to conclude the 13th Annual BIO CEO & Investor Conference.
|
|
BIO/Ipreo Release New Study Showing Investors Optimistic on Biotech’s FutureFeb 14 2011
The study is expected to inform and improve communications between biotech executives, shareholders and policymakers.
|
|
New Study Shows the Rate of Drug Approvals Lower than Previously ReportedFeb 14 2011
Biotechnology Industry Organization (BIO) Industry Analysis and BioMedTracker (BMT) announced results of a study today that shows the overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2010 is near one in 10.
|
|
New BIO Survey: U.S. Jobs, Patients, Competitiveness Benefitting from Therapeutic Discovery AwardsFeb 11 2011
According to a new survey of CEOs of small biotech firms that received Therapeutic Discovery Project awards last fall, the TDP is important to the viability of the companies receiving the award and allowed these small businesses to create or sustain jobs.
|
